AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+7.09%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$166M
AUM Growth
+$166M
(+11%)
Cap. Flow
+$18.9M
Cap. Flow
% of AUM
11.41%
Top 10 Holdings %
Top 10 Hldgs %
22.19%
Holding
254
New
38
Increased
43
Reduced
118
Closed
26
Top Buys
| 1 |
United Therapeutics
UTHR
|
$3.68M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$2.78M |
| 3 |
Pfizer
PFE
|
$2.64M |
| 4 |
Axsome Therapeutics
AXSM
|
$2.59M |
| 5 |
Corcept Therapeutics
CORT
|
$2.14M |
Top Sells
| 1 |
IMGN
Immunogen Inc
IMGN
|
$3.78M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
$3.13M |
| 3 |
ABVX
Abivax
ABVX
|
$2.86M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
$2.8M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
$2.22M |
Sector Composition
| 1 | Healthcare | 61.45% |
| 2 | Real Estate | 11.2% |
| 3 | Financials | 4.6% |
| 4 | Industrials | 3.92% |
| 5 | Technology | 2.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Immunovant
IMVT
$2.64B
| $1.23M | 0.74% |
38,000
| – | – |
|
52
AeroVironment
AVAV
$11.8B
| $1.23M | 0.74% |
+8,000
| New | +$1.23M |
|
|
RVNC
53
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.21M | 0.73% |
245,000
+25,000
| +11% | +$123K |
|
54
Intuitive Surgical
ISRG
$167B
| $1.2M | 0.72% |
3,000
-750
| -20% | -$299K |
|
55
Structure Therapeutics
GPCR
$1.12B
| $1.18M | 0.71% |
27,500
-2,500
| -8% | -$107K |
|
56
SoundHound AI
SOUN
$5.13B
| $1.18M | 0.71% |
200,000
| – | – |
|
57
Symbotic
SYM
$5.09B
| $1.13M | 0.68% |
25,000
| – | – |
|
58
Cabaletta Bio
CABA
$132M
| $1.11M | 0.67% |
+65,000
| New | +$1.11M |
|
59
Jazz Pharmaceuticals
JAZZ
$7.88B
| $1.02M | 0.62% |
8,500
-2,000
| -19% | -$241K |
|
60
Sagimet Biosciences
SGMT
$235M
| $1M | 0.6% |
+185,000
| New | +$1M |
|
61
Neurocrine Biosciences
NBIX
$14B
| $965K | 0.58% |
+7,000
| New | +$965K |
|
62
Roivant Sciences
ROIV
$8.39B
| $949K | 0.57% |
90,000
+35,000
| +64% | +$369K |
|
|
DCPH
63
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $944K | 0.57% |
+60,000
| New | +$944K |
|
64
Intuitive Machines
LUNR
$1B
| $938K | 0.57% |
+150,000
| New | +$938K |
|
|
VRNA
65
Verona Pharma
VRNA
$9.17B
| $901K | 0.54% |
56,000
| – | – |
|
66
Regal Rexnord
RRX
$9.75B
| $901K | 0.54% |
+5,000
| New | +$901K |
|
67
Allient
ALNT
$763M
| $892K | 0.54% |
+25,000
| New | +$892K |
|
68
Accuray
ARAY
$155M
| $865K | 0.52% |
+350,000
| New | +$865K |
|
69
AGNC Investment
AGNC
$10.1B
| $838K | 0.51% |
84,646
| – | – |
|
70
Acadia Pharmaceuticals
ACAD
$4.4B
| $832K | 0.5% |
45,000
+19,000
| +73% | +$351K |
|
71
Sanofi
SNY
$120B
| $729K | 0.44% |
+15,000
| New | +$729K |
|
72
Protagonist Therapeutics
PTGX
$3.68B
| $723K | 0.44% |
25,000
-5,000
| -17% | -$145K |
|
|
ONIT
73
Onity Group Inc.
ONIT
$336M
| $691K | 0.42% |
25,567
-2,628
| -9% | -$71K |
|
74
Globus Medical
GMED
$8.13B
| $671K | 0.4% |
+12,500
| New | +$671K |
|
75
Dyne Therapeutics
DYN
$1.88B
| $568K | 0.34% |
+20,000
| New | +$568K |
|